drugset / Trial / NCT01896440
Heart Safety Study of Ondansetron in Children Receiving Chemotherapy
RandomizedCrossoverQuadruple-blindTreatment
Summary
We will study the effects of ondansetron on measurements of electrical activity in the heart to make sure doses we are using to prevent nausea and vomiting in children receiving chemotherapy are safe.
Timeline
- Start
- 2013-10
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Ondansetron | Other / unclassified | 0.15 mg/kg | Intravenous |
| Comparator | Ondansetron | Other / unclassified | 0.3 mg/kg | Intravenous |